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Abstract
Attachment, spreading, and organization of endothelial cells into tubule networks are mediated by interactions
between cells in the extracellular microenvironment. Laminins are key extracellular matrix components and reg-
ulators of cell adhesion, migration, and proliferation. In this study, laminin-derived peptides were conjugated to
poly(ethylene glycol) (PEG) monoacrylate and covalently incorporated into degradable PEG diacrylate (PEGDA)
hydrogels to investigate the influence of these peptides on endothelial cellular adhesion and function in organiz-
ing into tubule networks. Degradable PEGDA hydrogels were synthesized by incorporating a matrix metallopro-
teinase (MMP)–sensitive peptide, GGGPQGIWGQGK (abbreviated PQ), into the polymer backbone. The
secretion of MMP-2 and MMP-9 by endothelial cells promotes polymer degradation and consequently cell migra-
tion. We demonstrate the formation of extensive networks of tubule-like structures by encapsulated human um-
bilical vein endothelial cells in hydrogels with immobilized synthetic peptides. The resulting structures were
stabilized by pericyte precursor cells (10T1/2s) in vitro. During tubule formation and stabilization, extracellular
matrix proteins such as collagen IV and laminin were deposited. Tubules formed in the matrix of metalloprotei-
nase sensitive hydrogels were visualized from 7 days to 4 weeks in response to different combination of peptides.
Moreover, hydrogels functionalized with laminin peptides and transplanted in a mouse cornea supported the in-
growth and attachment of endothelial cells to the hydrogel during angiogenesis. Results of this study illustrate the
use of laminin-derived peptides as potential candidates for modification of biomaterials to support angiogenesis.
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Introduction
Successful therapies in regenerative medicine havebeen primarily limited to thin or avascular tissues, such
as skin, cartilage, and bladder in which oxygen, nutrients,
and wastes diffuse through the extracellular space unassist-
ed.1,2 Generating larger and more complex tissues, such as
the heart, kidneys, or liver, requires the formation of a stable
microvascular network for prolonged cell viability and func-
tion. The normal development of blood vessels in the body is
mediated by signals between endothelial cells and the extra-
cellular matrix (ECM). These matrix interactions play an im-
portant part in many endothelial cell functions, including
adhesion, proliferation, migration, and differentiation.3,4
Based on our knowledge of this interplay, synthetic scaffolds
can be designed to mimic the vascular endothelial cell micro-
environment in an effort to guide and support blood vessel
formation in engineered tissues.
The vascular lumen is a hollow space composed of an en-
dothelial cell layer and an external sheath of mural cells sep-
arated by a laminin-rich basement membrane. Laminins,
which are critical to the structure of these tissues, make up
a family of heterotrimeric glycoproteins, with each protein
containing one a, b, and c chain.5,6 The a, b, and c subunits
characterize the functions and properties of the laminin pro-
teins. For example, the a chain is central in determining integ-
rin ligand specificity, whereas, the b subunit connects to the
cytoskeleton and affects multiple signaling pathways.7 Sev-
eral cell binding motifs based on laminin-derived peptides
have been investigated for approaches to modulate cell adhe-
sion and spreading, including those based on the RGD,
IKVAV, and YIGSR amino acid sequences.8,9 The extensively
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studied RGD sequence is found in many ECM proteins and
serves as the binding motif for cell surface integrin recep-
tors. For example, human umbilical vein endothelial cells
(HUVECs) seeded upon RGDS-modified poly(ethylene gly-
col) diacrylate (PEGDA) hydrogels showed increased spread-
ing and adhesion 24-h postseeding compared with the same
cells on the unmodified polymer or polymer modified with
RGES.10 In other work with this peptide, poly(ethylene gly-
col) (PEG) hydrogels functionalized with protease-cleavable
peptide sequences and RGDS showed that immobilized
RGDS facilitated initial cell adhesion, while degradation of
the polymer from cell-secreted matrix metalloproteinases
(MMPs) promoted the formation of vascular networks in co-
cultures of endothelial and mesenchymal stem cell progenitor
cells.11 Furthermore, adhesion and proliferation studies using
HUVECs indicated that cells spread better on the RGDS-
modified surface.12,13
IKVAV, a peptide derived from the a-chain of laminin, has
been previously shown to induce endothelial cell adhesion
and subsequent tubule formation. In a study conducted by
Grant et al.,14 the IKVAV peptide demonstrated increased en-
dothelial cell mobilization, capillary branching, and vessel
formation in both a murine angiogenesis assay and experi-
ments with the chick yolk sac/chorioallantoic membrane. In
the presence of immobilized IKVAV on collagen type I hydro-
gels, vascular endothelial cells stimulated cell migration, ad-
hesion, and capillary network formation.15 This peptide has
also been shown to mediate revascularization of ischemic tis-
sue,16 making it of great interest to those seeking to induce
microvascular networks de novo.
The integrin receptor ligand YIGSR, found in a cysteine-
rich site of the laminin b chain, has been extensively investi-
gated as a mediator of cell adhesion.17,18 Various studies
have demonstrated that YIGSR plays a key role in endothelial
cell-to-cell interactions and tubule formation.12,19,20 In one
study, incorporation of YIGSR in a polyurethane urea scaf-
fold resulted in improvement in endothelial cell adhesion,
proliferation, migration, and ECM production.18–21 In an-
other study, surface presentation of both RGD and YIGSR
peptides was shown to induce endothelial cell tubule forma-
tion over unmodified materials.19 When RGD and YIGSR
were tested separately, YIGSR-modified matrigel induced en-
dothelial cells to organize in tubules, while RGD-modified
matrigel only supported cell attachment, providing key evi-
dence that these peptides have separate effects on endothelial
cells with the primary role of RGD in cell attachment and
YIGSR in tubule formation.19
In the present study, we demonstrate that the degree of en-
dothelial cell tubule formation varies with the peptide se-
quence presented in the material. PEGDA hydrogels were
selected as the synthetic scaffold for these studies due to
their innate ability to resist protein adsorption and nonspe-
cific cell adhesion.11 This polymeric material acts as a
‘‘blank slate’’ into which selective functionality can be incor-
porated by covalent attachment of proteins and peptides, in-
cluding those that mediate cell adhesion and others that are
susceptible to biodegradation. As such, this creates a con-
trolled microenvironment in which interactions with cells
are driven primarily by the incorporated biomolecules.
Importantly, PEGDA hydrogels are generated in a photocros-
slinking process consisting of mild conditions that permit cel-
lular encapsulation with high viability.11,22
Laminin-derived peptides were conjugated to heterobi-
functional PEG chains and covalently incorporated in hydro-
gels. In response to these immobilized peptides, encapsulated
HUVECs organized into extensive networks of capillary-like
three-dimensional (3D) structures. Pericyte precursor cells
(10T1/2s) stabilized the resulting structures. Additionally,
hydrogels incorporated with laminin-derived peptides and
implanted in the mouse cornea stimulated the formation of
functional blood vessels. This work shows that YIGSR,
IKVAV, and RGD peptides have different abilities to modu-
late vessel assembly and long-term tubule stability both
in vitro and in vivo. Based on these results, we believe that
laminin-derived peptides can be immobilized in synthetic
scaffolds and exploited as a strategy for regulating the forma-
tion of microvasculature in tissue-engineered constructs.
Material and Methods
Cell maintenance
HUVECs (Lonza, Walkersville, MD) were grown in endo-
thelial growthmedium (EGM-2), supplementedwith ascorbic
acid, epidermal growth factor, fibroblast growth factor
(hFGF-2), heparin, hydrocortisone, insulin-like growth factor,
GA-1000 (gentamicin, amphotericin-B), and 2% fetal bovine
serum (Lonza). 10T1/2 pericyte precursor cells (American
Type Culture Collection, Manassas, VA) were cultured in
Dulbecco’s modified Eagle’s medium (DMEM; Gibco, North
Andover, MA) supplemented with 10% fetal bovine serum
and 2mM L-glutamine, 1000U/mL penicillin, and 100mg/
L streptomycin (Sigma, St. Louis, MO). Experiments were
conducted with HUVECs from passages 2 to 5, and 10T1/2
cells from passages 15 to 18. All cells were incubated at
37C and at 5% CO2.
Peptide synthesis
The laminin-derived sequences YIGSR and IKVAV were
synthesized on an APEX 396 solid phase peptide synthesizer
(AAPPTec, Louisville, KY) using standard Fmoc chemistry.
After purification, the peptides were characterized via
matrix-assisted laser desorption/ionization-time-of-flight
mass spectrometry (MALDI-ToF; Bruker Daltonics, Billerica,
MA). The same methods were used to generate the protease-
sensitive peptide sequence, GGGPQGIWGQGK (PQ), which
has been shown to render synthetic hydrogels degradable
when incorporated into the polymer backbone.11,22 MMP-2
and MMP-9, secreted by endothelial cells, cleave the PQ pep-
tide in the polymer backbone, resulting in the degradation of
PEG hydrogel.
Polymer conjugation
The cell-adhesive peptide RGDS (American Peptide, Sun-
nyvale, CA), was conjugated to acryloyl-PEG-succinimidyl
carboxymethyl (PEG-SCM, 3400 Da, Laysan Bio Inc., Arab,
AL) to form PEG-RGDS (Fig. 1). In this reaction, the RGDS
peptide was first dissolved in anhydrous dimethyl sulfoxide
with 2lL of diisopropylethylamine and then added drop
wise to dry acryloyl-PEG-succinimidyl carboxymethyl at a
molar ratio of 1:1.2 (PEG:peptide). The resulting product
was then purified via dialysis against water in a regenerated
cellulose membrane (MWCO 5000; Spectrum Laboratories,
Inc., Rancho Dominguez, CA) and lyophilized. Successful
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conjugation of the peptide to PEG was confirmed via a gel
permeation chromatography system equipped with UV-VIS
and evaporative light scattering detectors (GPC, Polymer
Laboratories, Amherst, MA).. The same protocols were fol-
lowed for the laminin peptides, YIGSR and IKVAV, to yield
PEG-IKVAV and PEG-YIGSR. The PQ peptide conjugation
was achieved in process similar to that for PEG-RGDS but
with a PEG-SCM:PQ peptide molar ratio of 2:1 generating
an MMP-degradable segment that was flanked on both
sides by PEG (PEG-PQ-PEG).
Encapsulation of endothelial cells and 10T1/2 pericyte
precursors in degradable hydrogels
HUVECs and 10T1/2 cells were encapsulated in degrad-
able hydrogels in order to observe the effects of covalently
immobilized IKVAV and YIGSR on tubule formation.
HUVECs and 10T1/2 cells were encapsulated at ratio of 4:1.
Hydrogels were formed from prepolymer solutions com-
posed of 10% (w/v) PEG-PQ-PEG in sterile HEPES buffered
saline (HBS) containing 1.5% (v/v) triethanolamine, 1mM
eosin Y, and 3.95 lL/mL N-vinyl-2-pyrrolidone (NVP).
PEG-peptides were added to the prepolymer solution to cre-
ate four treatment groups: (1) 3.5mM PEG-IKVAV, (2)
3.5mM PEG-YIGSR, (3) 3.5mM PEG-IKVAV with 1.0mM
PEG-RGDS, and (4) 3.5mM PEG-YIGSR with 1.0mM PEG-
RGDS. A prepolymer solution containing 3.5mM PEG-
RGDS alone was used as a control group. HUVECs and
10T1/2 cells were harvested using trypsin-EDTA and pel-
leted by centrifuging at 700 g for 4min. The cell pellets
were then resuspended in the prepolymer solutions to con-
centrations of 10,000 cells/lL. Five-microliter droplets of
cell-laden polymer were sandwiched between a Sigma-
coated (Sigma) glass slide and an acrylated cover glass sepa-
rated by a 380-lm polydimethylsiloxane (PDMS) spacer. The
solutions were cross-linked under white light for 35 sec to
form hydrogels that were then immersed in EGM-2 media
and incubated at 37C in a 5% CO2 environment for up to
28 days. Media on the hydrogels was replenished every
other day.
Assessing tubule morphology and ECM protein production
Endothelial cell tubule formation was evaluated by mea-
suring total tubule length per field of view and average tu-
bule diameter in hydrogels that were stained to visualize
actin filaments and cell nuclei. Hydrogels were first fixed in
4% paraformaldehyde for 20min and then washed with
phosphate-buffered saline (PBS, pH 7.4). Next, a 0.5%
Triton-X solution was added for 30min to permeabilize en-
capsulated cells. Following another PBS wash, nonspecific
binding was blocked by incubation with 1% bovine serum
albumin (BSA) overnight. Gels were finally exposed to a
1:100 dilution of rhodamine phalloidin (Invitrogen, Carlsbad,
CA) containing 2lM 4¢,6-diamidino-2-phenylindole (DAPI)
in HBS with 0.1% BSA for 2 h to stain actin and cell nuclei, re-
spectively. The hydrogels were visualized using a confocal
microscope (Zeiss 5-LIVE, Plan-Apochromat 20· objective
with 0.8 NA) with a z-stack depth of 20 lm. Imaris analysis
software (Bitplane Inc., South Windsor, CT) was used to
trace and measure tubule length and tubule diameter in
three fields of view for each hydrogel (n = 3 hydrogels per ex-
perimental group, FOV = 318 lm · 318lm).23,24
To elucidate collagen IV and laminin production, hydro-
gels were first blocked with 1% BSA overnight and then incu-
bated with primary antibodies on a rocker table at 4C for an
additional overnight period to insure antibody infiltration
into the samples. For these studies, primary antibodies in-
cluded rabbit anticollagen IV (1:100 in PBS with 0.1% BSA,
Abcam, Cambridge, MA) and chicken antilaminin (1:200 in
PBS with 0.1% BSA, Sigma). Hydrogels were rinsed in PBS
five times at 1-h intervals and then incubated with a 1:400 di-
lution of Alexa Fluor 488 donkey antirabbit IgG (Invitrogen)
or Alexa Fluor 488 goat antichicken IgG (Invitrogen) over-
night at 4C to visualize the primary antibodies. Subse-
quently, samples were rinsed with PBS and then imaged
using a confocal microscope under a 20· objective. Image sli-
ces of 1-lm thickness from a z-stack of 20lm deep in the gel
were taken for three fields of view from each of three hydro-
gels. Relative amounts of laminin and collagen IV were deter-
mined bymeasuring Alexa Fluor 488 pixel intensity in ImageJ
(National Institutes of Health, Bethesda, MD) and normaliz-
ing to cell number using the DAPI pixel intensity.
In vivo angiogenesis assay: hydrogel implantation
into the mouse cornea
All animal procedures applied in this study were approved
by the Institutional Animal Care and Use Committee (IACUC)
at Baylor College of Medicine. In order to assess the effects of
laminin peptides on tubule formation in vivo, degradable
PEGDA hydrogels were implanted into the corneas of Flk1-
myr::mCherry transgenic mice according to previously pub-
lished procedures.25 Transgenic mice express an endothelial
cell–specific fluorescent protein that allows formed tubules to
be visualized via fluorescence microscopy.26 Briefly, a Von
Graefe knife was used to generate micropockets by partial
thickness incisions into the cornea of anesthetized mice.
Hydrogels were formed from prepolymer solutions composed
of 10% (w/v) PEG-PQ-PEG in sterile HBS containing 10lL/
mL of 300mg/mL 2,2-dimethoxy-2-phenylacetophenone
FIG. 1. The cell-adhesive peptide, RGDS, was conjugated to acryloyl-PEG-succinimidyl carboxymethyl (PEG-SCM, 3400 Da)
to form PEG-RGDS. Similar reactions were used to conjugate the additional laminin peptides, yielding PEG-IKVAV and
PEG-YIGSR.
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(DMAP) in NVP and 320 ng of soluble PDGF-BB and 80ng of
FGF-2 per gel. PDGF-BB and FGF-2 were added to the gels to
initiate the angiogenic response of vessels from the limbus of
the eye. PEG-peptides were added to the prepolymer solution
to create four treatment groups: (1) 3.5mM PEG-IKVAV, (2)
3.5mM PEG-YIGSR, (3) 3.5mM PEG-IKVAV with 1.0mM
PEG-RGDS, and (4) 3.5mM PEG-YIGSR with 1.0mM PEG-
RGDS. A prepolymer solution containing 3.5mM PEG-
RGDS alone was used as a control. Once hydrogel solutions
were formulated, 0.12 lL of polymer solution was injected
into a mold made of two glass slides separated by a 125-lm
PDMS spacer. Following 2min of exposure to UV light
(365 nm, 10mW/cm2), the polymerized gels were immedi-
ately implanted in the cornea micropockets. For analysis of
blood vessel structure and angiogenesis, mice corneas were
harvested 7 days postimplantation and fixed in 4% formalde-
hyde. A 543-nm laser was used to excite the mCherry fluoro-
phore in order to visualize and acquire z-stack images of
endothelial cells that had migrated and invaded into the
modified hydrogels. FARSIGHT software (http://farsight-
toolkit.org/wiki/Main_Page) was used to measure vessel di-
ameter and count vessel branch points in the acquired images
(n = 5–7). The space filling parameters of fractal dimension,
lacunarity, and vessel density were also quantified as previ-
ously reported27 to examine the extent of the angiogenic re-
sponse to the modified hydrogels (n= 5–7). The lacunarity
parameter describes the spatial distribution between vessel
beds,27 and fractal dimension uses box-counting algorithms
to measure object morphology, which helps to quantify the
complexity of vessel beds.27
Statistics
Single factor ANOVA and subsequent Bonferroni post
hoc tests were used to analyze vessel formation and ECM
production. For each analysis, p < 0.05 was considered to
be significant.
Results
Encapsulated endothelial cells exposed to laminin-derived
peptides form tubule networks
HUVECs and pericyte-precursor cells encapsulated in de-
gradable PEGDA hydrogels underwent tubulogenesis with
the extent of this response dependent upon the combination
of laminin-derived peptides included in the polymer matrix.
The tubule networks were visualized as early as 7 days
after encapsulation by staining for cell nuclei via DAPI and
actin filaments via phalloidin (Fig. 2A). Tubules persisted
up to 28 days, with the highest tubule formation response ob-
served in hydrogels with both PEG-YIGSR and PEG-RGDS.
To quantify the tubule formation response, average tubule di-
ameter and total tubule length were calculated and evaluated
using a single-factor ANOVA and Bonferroni post hoc test
(Supplementary Fig. S1). All groups, when compared indi-
vidually, showed an increase in tubule diameter and total
FIG. 2. Images of cells in modified hydrogels (A) were taken after 7 days in culture. To quantify the resulting tubule forma-
tion in vitro, the average tubule diameter (B) and total tubule length per field of view (C) were calculated. *Significantly dif-
ferent from all other groups for time point 14 days in culture ( p< 0.01). xSignificantly different from all other groups at time
point 28 days in culture ( p< 0.01). Supplementary Fig. S1 shows all individual significant differences between laminin peptide
groups and their effect on average tubule diameter and total tubule length per volume.
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tubule length over time (Fig. 2B, 2C). Additionally, cells that
were exposed to a combination of PEG-YIGSR and PEG-
RGDS had a significantly higher tubule length and tubule di-
ameter when compared with all other treatment groups
( p< 0.01).
Collagen IV and laminin expression in tubule networks
ECM proteins are generated by vessel cells in the process of
tubule formation and establishment of long-term stability. In
light of this, immunohistochemistry was performed to mea-
sure production of collagen IV and laminin in the experimen-
tal hydrogels. Regions of defined tubule formation in
hydrogels were found to correspond to areas with high
amounts of collagen IV deposition (as measured by pixel in-
tensity). Specifically, cells exposed to a combination of PEG-
YIGSR and PEG-RGDS showed the highest expression of
this important ECM protein (Fig. 3), which was further
found to increase over time and to be dependent on the
type peptide sequences presented. In treatment groups with
PEG-YIGSR alone and combinations of PEG-IKVAV or
PEG-YIGSR with PEG-RGDS, the amount of collagen IV in-
creased significantly from 7 to 28 days ( p < 0.05) as tubules
were stabilized and maturing. For all time points, collagen
IV production by cells was significantly higher ( p< 0.01) in
gels with PEG-YIGSR compared with those with PEG-
IKVAV. Furthermore, the addition of PEG-RGDS to PEG-
IKVAV or PEG-YIGSR induced more collagen production
than PEG-IKVAV or PEG-YIGSR being presented alone. For
example, at 14 days, the amount of collagen production in
hydrogels with PEG-YIGSR co-immobilized with PEG-
RGDS was 35% greater than with PEG-YIGSR alone. Com-
plete Bonferroni post hoc analysis of this data is provided in
Supplementary Fig. S2.
Laminin deposition was also highly dependent on the pep-
tide sequences presented, as evidenced by significantly
higher ( p < 0.05) protein accumulation in all treatment groups
containing PEG-YIGSR compared with those with PEG-
IKVAV alone (Fig. 4). Specifically, at 7 days hydrogels with
PEG-YIGSR contained 25% more laminin than those with
PEG-IKVAV.
PEG-laminin peptides enhance the in vivo
vascular response
To investigate the impact of laminin-derived peptides
in vivo, hydrogels were implanted into corneal micropockets
created in Flk1-myr::mCherry transgenic mice. Using this well-
established angiogenesis assay,11,25 we demonstrated that the
addition of IKVAV and YIGSR peptides to PEGDA hydrogels
enhances cell–cell attachment and organization as visualized
by the mCherry fluorescence of mouse endothelial cells (Fig.
5). Soluble PDGF-BB and FGF-2 were added to the hydrogels
with immobilized peptides to induce angiogenesis from the
limbal vessels of the eye. Covalent immobilization of either
PEG-IKVAV or PEG-YIGSR with PEG-RGDS produced tu-
bules with a significantly greater vessel density and tubule
branching than did treatment groups with either peptide
FIG. 3. The amount of ECM proteins produced by tubules was dependent on the type of peptide presented to encapsulated
cells. Images of cells in modified hydrogels (A)were taken after 14 days in culture (B). Laminin deposition was quantified and
was found to correlate to the growth of tubules. Increase in laminin production (shown in green) by cells was observed as the
time in culture was prolonged from 7 days to 28 days. Refer to Supplementary Fig. S2 for individual significant differences
between laminin peptide groups and their effect on collagen IV production.
LAMININ PEPTIDES AND ENDOTHELIAL CELL TUBULOGENESIS 5
FIG. 5. As visualized by the mCherry fluorescence of mouse endothelial cells (A), the presence of PEG-YIGSR and PEG-RGDS
induced a significant difference in vessel density (B), fractal dimension (C), lacunarity (D), vessel diameter (E), and branch points
(F). *Significantly different from PEG-YIGSR and PEG-IKVAV ( p<0.01). xSignificantly different from PEG-YIGSR and PEG-RGDS
(p<0.05). #Significantly different from PEG-RGDS (p<0.05). USignificantly different from all other groups (p<0.05). Scale bar=50
lm. {Significantly different from all other groups (p<0.01). +Significantly different from PEG-YIGSR and PEG-IKVAV (p<0.05).
FIG. 4. The amount of extracellular matrix (ECM) proteins produced by tubules was dependent on the type of peptide pre-
sented to encapsulated cells. Images of cells in modified hydrogels (A) were taken after 14 days in culture (B). Collagen IV
deposition shown in green was quantified and found to correspond to areas of high tubule formation. This result is noticeable
for all time points up to 28 days for the PEG-YIGSR/PEG-RGDS combination. Refer to Supplementary Fig. S2 for individual
significant differences between laminin peptide groups and their effect on laminin production.
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alone ( p < 0.01). Additionally, space-filling parameters were
analyzed to quantify vessel morphology. With the inclusion
of both PEG-YIGSR and PEG-RGDS in implanted hydrogels,
vessels with a higher lacunarity parameter ( p < 0.05) and
greater fractal dimension ( p< 0.01) were produced, indicative
of more complex, better defined vessel networks. Conversely,
presentation of PEG-IKVAV in combination with PEG-RGDS
induced vessels of smaller diameter, suggesting that the type
of peptide presented in vivo plays a critical role in determin-
ing vessel morphology.
Discussion
Survival of engineered tissues depends heavily upon the
formation of a microvasculature network to achieve sufficient
perfusion. Delay in the development of vessels throughout
engineered constructs can cause local oxygen and nutrients
to deplete, contributing to the death of transplanted cells and
failure of the implant. Our current study exploiting immobi-
lized laminin-derived peptides to boost cell–cell interactions
shows the efficacy of an alternative approach for forming
long-lasting tubule structures. Specifically, immobilized
RGDS, YIGSR, and IKVAV, which are known to influence
cell migration and invasion, have been used to induce tubule
formation in biofunctional hydrogels. In 3D degradable scaf-
folds, PEG-YIGSR and PEG-IKVAV alone and in combination
with PEG-RGDS induced HUVEC tubule formation as early as
7 days, with some groups showing persistent tubules up to 4
weeks. This result is desirable because one of the main aims
in tissue engineering is to rapidly form stable vessels that
can promote the survival of implanted cells. In comparison
with all other treatment groups, cells exposed to PEG-YIGSR
in combination with PEG-RGDS arranged in more stable tu-
bule networks with a significant increase in total tubule length
and average diameter over a 4-week period. For example, at 28
days, tubules in hydrogels with PEG-YIGSR and PEG-RGDS
were 86% greater in length than those with only PEG-RGDS.
The biological effects of YIGSR are mediated by its binding
to a 67-kDa laminin receptor.18,28 The 67-kDa laminin receptor
mediates cell attachment and spreading. Increased expression
of the receptor correlates with cell proliferation and migra-
tion.28 Endothelial cells have been reported to express high
levels of 69-kDa laminin-binding receptor that is localized
with actin filaments.29 The carboxyl terminal of 67-kDa lami-
nin receptor binds to the peptide YIGSR which induces
down regulation ofmitogen-activated protein kinase phospha-
tase-1 (MKP-1) expression and dephosphorylation of mitogen-
activated protein kinase (MAPK).28 Higher MAPK activity
induced by the 67-kDa laminin receptor has been implicated
previously to correlate with expression of MMPs and to en-
hance vessel invasion, growth, and angiogenesis.30
The trend of increased vessel growth in the presence of
YIGSR correlates well with previous in vivo and in vitro stud-
ies that have shown the peptide promotes attachment, prolif-
eration, migration, and spreading of endothelial cells.17–19,21
In a recent study, endothelial cells seeded in polyurethane
urea-modified PEG scaffolds containing YIGSR showed higher
levels of cell migration and collagen production.21 Other stud-
ies have shown that when RGDS and YIGSR sequences were
covalently attached to amino phase glass, endothelial cell at-
tachment and spreading were enhanced significantly.31 Addi-
tionally, though RGDS has been shown to promote cell
binding, YIGSR enhances cell-to-cell interactions.18,19 Results
from the current study suggest that if RGDS and YIGSR are
presented simultaneously from the commencement of complex
cell interactions, their signaling is synergistic and promotes for-
mation of mature, stable vessels. In fact, vessel density was sig-
nificantly higher in hydrogels with both YIGSR and RGDS
then hydrogelswith YIGSR alone. The possibility of a synergis-
tic effect is further supported by the fact that collagen IV pro-
duction for the PEG-RGDS/PEG-YIGSR combination was
significantly greater for the duration of the 4 weeks as com-
pared with any of the other experimental groups. The in vivo
results corroborate this findingwith a significantly greater ves-
sel density and more extensive branching for the PEG-YIGSR/
PEG-RGDS treatment as compared to PEG-YIGSR alone. After
only 7 days in vivo, the average blood vessel density under
combined PEG-YIGSR and PEG-RGDS conditions was ap-
proximately twice that of hydrogels with only PEG-RGDS or
only PEG-YIGSR. This suggests that the presence of the
RGDS peptide further enables YIGSR to initiate formation of
complex, defined vasculature. Previous studies have reflected
signs of a synergistic relationship between these two pep-
tides.31,32 In a study of bovine artery cell adhesion, cells ex-
posed to YIGSR and RGDS sequences in combination
adhered more readily to amino phase glass.31 The synergistic
effect was also observed in modified fluorinated ethylene pro-
pylene films, which displayed greater neural cell aggregation
and anchorage in the presence of the two peptides.32 These
combination effects on cell adhesion, aggregation, andmotility
increase the likelihood that such a relationship may hold true
for tubule formation in angiogenesis as well.
Hydrogels modified with laminin-derived peptides and
implanted in the mouse cornea induced vessel formation,
with a particularly heightened response when the materials
contained a combination of YIGSR and RGDS. These in vivo
results seem to indicate that the morphology of induced ves-
sels can be tuned based on the types of biomimetic peptides
presented. In other words, tissues requiring tortuous vessels
with large diameters and a greater number of branch points
might require a different cocktail of peptides than those
with more uniform, small diameter vessels. In the current
study, fractal dimension was quantified in order to assess ves-
sel complexity and definition, while lacunarity was measured
to examine cell distribution uniformity within the vascula-
ture.27 Interestingly, the addition of RGDS to IKVAV or
YIGSR causes the fractal dimension and the lacunarity pa-
rameter to increase as compared with IKVAV or YIGSR
alone. This suggests that with the addition of specific pep-
tides the complexity and distribution of tubules can be
altered. Results also show that the response to a YIGSR-
RGDS combination includes vessels of greater diameters
than IKVAV-RGDS. Further, tubules formed in gels with
YIGSR or IKVAV co-immobilized with RGDS have a larger
tubule diameter in vitro than gels with YIGSR or IKVAV
alone. This suggests that specific combination of these pep-
tides results in different vessel morphologies. Hydrogels
with IKVAV or RGDS immobilized separately show no
change in total tubule length or diameter over 4 weeks
in vitro. Similar findings were illustrated when combinations
of cell adhesion peptides derived from laminin (YIGSR and
PDSGR) and fibronectin (PHSRN and RGDS) were covalently
attached to a PDMS substrate to facilitate the adhesion of cor-
neal epithelial cells.33 Multiple peptides on the substrate
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resulted in greater adhesion than modification with the indi-
vidual peptides.
The mechanism by which these laminin-derived peptides
stabilize tubule formation may be related to production of
basement membrane proteins, including laminin and colla-
gen IV, because the ECM layer is necessary for tissue devel-
opment and vessel stabilization.32,34 In the current work, the
accumulations of both laminin and collagen IV were shown
to depend on the type and combination of peptides pre-
sented, and laminin deposition, in particular, varied signifi-
cantly with time in culture. Previous studies suggest that the
varied composition and structural organization of the ECM
during vessel development may have important effects on
endothelial cell behavior and tubule morphogenesis.32,34 In
this process, the maturation of vessels is accompanied by
an increase in laminin,6,35 and collagen IV influences the
structural integrity of the basement membrane.36,37 Endo-
thelial cell binding to laminin and collagen IV is mediated
by integrins and influences cell migration and prolifera-
tion.6,35–37 Cell binding to both proteins is regulated by the
avb3 integrin, which is the same integrin that was shown
to induce endothelial cell adhesion in response to immobi-
lized peptide fragments such as IKVAV and YIGSR.38 As
such, inhibition of avb3 integrins has been shown to prevent
deposition of ECM proteins.39,40 Furthermore, several find-
ings suggest that laminin fragments such as IKVAV and
YIGSR can induce greater susceptibility to cell-triggered
proteolysis, which permits cell invasion and subsequent
ECM matrix remodeling, both of which are necessary for tu-
bule formation.41,42
Conclusion
In this study, we have shown that cellular response can be
augmented by introducing short laminin-derived peptide se-
quences to synthetic scaffolds. In particular, combinations of
these biomimetic sequences, which are known to regulate the
adhesion, migration, and proliferation of endothelial cells, in-
stigated the formation of stable tubules with well-developed
ECM in vitro and in vivo.20,43 The covalently immobilized cell
adhesion ligands PEG-RGDS, PEG-IKVAV, and PEG-YIGSR
have differing effects on tubule formation when presented
to endothelial and pericyte precursor cells individually or in
combinations. Presentation of a PEG-RGDS/PEG-YIGSR
combination induced greater tubule length and diameter
in vitro, while resulting in greater vessel density and branch-
ing in vivo. In the in vitro experiment, the amounts of collagen
IV and laminin, which are ECM proteins involved in vessel
stabilization, increased with time from 7 to 28 days and
were also found to be dependent on the type of peptides pres-
ent. Finally in a mouse cornea angiogenesis model, hydrogels
incorporating a combination of PEG-YIGSR and PEG-RGDS
resulted in vessels with a statistically significant increase in
key morphological parameters, highlighting the ability of
this formulation to encourage microvascular network forma-
tion in tissue engineered constructs. Overall, the results of this
study indicate that laminin-derived peptides localized in a
polymer matrix can enhance the formation of blood vessels
within the construct. Enhancing vascularization in synthetic
scaffolds can promote survival of transplanted cells and
ultimately compensate for the loss of function in tissues or
organs.
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